I-Mab Out-Licenses Bi-Specific to South Korea’s ABL Bio in $100 Million Deal Jul 26, 2018 Life Science
KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma Jul 26, 2018 Life Science
GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research Jul 25, 2018 Life Science
Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory Jul 25, 2018 Life Science
Hillhouse Capital Leads $230M Series B Preferred Stock Financing In US Biopharmaceutical Firm Gossamer Bio Jul 24, 2018 Life Science
Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing Plan Jul 24, 2018 Life Science
Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer Jul 24, 2018 Life Science
CICC’s Subsidiary Leads $103M Series B In Tumor Radiotherapy Start-up Allcure Medical Jul 23, 2018 Life Science
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China Jul 23, 2018 Life Science
BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor Jul 23, 2018 Life Science
Long Hill Capital Closes $265 Million Second Fund for China Health Investments Jul 23, 2018 Life Science
Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year Jul 20, 2018 Life Science
Kolon Life Science to Export $207 Million of Gene Therapy Treatment to China’s Hainan Province Jul 20, 2018 Life Science
Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA Sequencer Jul 20, 2018 Life Science
